Lupin is passionate about advancing health and addressing the unmet needs of patients. To do this, we must closely enagage with healthcare organisations (HCOs) and Healthcare professionals (HCPs) for scientific expertise.
We provide payments and funding to HCPs for their time and expertise. We also provide funding to HCOs to support patient care or to benefit the NHS, and to organisations for research and development (R&D).
The pharmaceutical industry is committed to greater transparency of financial relationships with HCPs and HCOs.
We adhere to the Association of the British Pharmaceutical Industry (ABPI) code and will disclose payments and benefits to HCPs and HCOs. Lupin discloses details of certain Transfer of Value (ToV) payments and benefits to individually named HCPs and HCOs on a publicly searchable database, Disclosure UK, which is hosted on the ABPI website.
Full disclosure of value for 2020 will be published in June 2021.